Expression of interleukin-33 and ST2 in nonrheumatic aortic valve stenosis

被引：16
|
作者：
Sawada, Hisashi [1 ]
Naito, Yoshiro [1 ]
Hirotani, Shinichi [1 ]
Akahori, Hirokuni [1 ]
Iwasaku, Toshihiro [1 ]
Okuhara, Yoshitaka [1 ]
Miki, Kojiro [1 ]
Eguchi, Akiyo [1 ]
Mitsuno, Masataka [2 ]
Miyamoto, Yuji [2 ]
Ohyanagi, Mitsumasa [3 ]
Tsujino, Takeshi [4 ]
Masuyama, Tohru [1 ]
机构：
[1] Hyogo Coll Med, Dept Internal Med, Div Cardiovasc, Nishinomiya, Hyogo 6638501, Japan
[2] Hyogo Coll Med, Dept Cardiovasc Surg, Nishinomiya, Hyogo 6638501, Japan
[3] Hyogo Coll Med, Dept Internal Med, Div Coronary Heart Dis, Nishinomiya, Hyogo 6638501, Japan
[4] Hyogo Univ Hlth Sci, Dept Pharm, Kobe, Hyogo, Japan
来源：
INTERNATIONAL JOURNAL OF CARDIOLOGY | 2013年 / 168卷 / 01期
关键词：
Aortic valve stenosis; Inflammation; Interleukin-33; ST2; IL-33;
D O I：
10.1016/j.ijcard.2012.12.059
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：529 / 531
页数：3
相关论文
共 50 条
  • [21] Critical roles of interleukin-33/suppression of tumorigenicity 2 (IL-33/ST2) in pulmonary disorders
    Xu Jiao
    Tang Jianlei
    中华医学杂志英文版, 2022, 135 (12) : 1508 - 1510
  • [22] Interleukin-33/ST2 Axis as Potential Biomarker and Therapeutic Target in Kawasaki Disease
    Seigo Okada
    Hiroki Yasudo
    Yuji Ohnishi
    Chie Matsuguma
    Reiji Fukano
    Takahiro Motonaga
    Takako Waniishi
    Shunji Hasegawa
    Inflammation, 2023, 46 : 480 - 490
  • [23] Serum soluble ST2 and interleukin-33 levels in patients with pulmonary arterial hypertension
    Carlomagno, Guido
    Messalli, Giancarlo
    Melillo, Rosa Marina
    Stanziola, Anna Agnese
    Visciano, Carla
    Mercurio, Valentina
    Imbriaco, Massimo
    Ghio, Stefano
    Sofia, Matteo
    Bonaduce, Domenico
    Fazio, Serafino
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 168 (02) : 1545 - 1547
  • [24] Serum levels of Interleukin-33 and its soluble receptor ST2 in asthmatic patients
    Azazi, Ensaf A.
    Elshora, Ashraf E.
    Tantawy, Enas A.
    Elsayd, Marwa A.
    EGYPTIAN JOURNAL OF CHEST DISEASES AND TUBERCULOSIS, 2014, 63 (02): : 279 - 284
  • [25] Altered Site-Specific Expression Patterns of Interleukin-33 and its Receptor ST2 in COPD Lungs
    Sanden, C.
    Siddhuraj, P.
    Jonsson, J.
    Lindo, C.
    Nys, J.
    Schofield, D.
    Scott, I.
    Lindstedt, S.
    Kolbeck, R.
    Humbles, A.
    Lutter, R.
    Cohen, S.
    Erjefalt, J.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [26] Critical roles of interleukin-33/suppression of tumorigenicity 2 (IL-33/ST2) in pulmonary disorders
    Xu, Jiao
    Tang, Jianlei
    CHINESE MEDICAL JOURNAL, 2022, 135 (12) : 1508 - 1510
  • [27] Interleukin-33/ST2 system attenuates aldosterone-induced adipogenesis and inflammation
    Martinez-Martinez, Ernesto
    Cachofeiro, Victoria
    Rousseau, Elodie
    Alvarez, Virginia
    Calvier, Laurent
    Fernandez-Celis, Amaya
    Leroy, Celine
    Miana, Maria
    Jurado-Lopez, Raquel
    Briones, Ana M.
    Jaisser, Frederic
    Zannad, Faiez
    Rossignol, Patrick
    Lopez-Andres, Natalia
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2015, 411 (0C) : 20 - 27
  • [28] Interleukin-33/ST2 Axis as Potential Biomarker and Therapeutic Target in Kawasaki Disease
    Okada, Seigo
    Yasudo, Hiroki
    Ohnishi, Yuji
    Matsuguma, Chie
    Fukano, Reiji
    Motonaga, Takahiro
    Waniishi, Takako
    Hasegawa, Shunji
    INFLAMMATION, 2023, 46 (01) : 480 - 490
  • [29] Interleukin-33 and receptor ST2 as indicators in patients with asthma: a meta-analysis
    Li, Rui
    Yang, Gang
    Yang, Ruiqi
    Peng, Xiaoxing
    Li, Jing
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (09): : 14935 - 14943
  • [30] Interleukin-33 and Soluble ST2 Levels in Infants with Hypoxic-Ischemic Encephalopathy
    Hamano, Hiroki
    Takahashi, Kazumasa
    Kimura, Sasagu
    Matsuguma, Chie
    Kaneyasu, Hidenobu
    Fujimoto, Yosuke
    Ohta, Naoki
    Okada, Seigo
    Hasegawa, Shunji
    NEONATOLOGY, 2023, 120 (03) : 353 - 362
12345